 |
|
|
| Date: | Sunday, June 13 2004 |
| Time: | 08:30-09:45 |
| Room: | Le Mont-Blanc / Le Cervin, Geneva Palexpo |
| 08:30-08:45 |
587 |
|
|
INTENSIVE CONSOLIDATION VERSUS ORAL MAINTENANCE THERAPY IN PATIENTS >60 YEARS WITH ACUTE MYELOID LEUKEMIA: RESULTS OF THE RANDOMIZED AML HD98B TRIAL OF THE AMLSG ULM
F. Schlenk, S. Fröhling, F. Hartmann, J.TH. Fischer, A . Glasmacher, F. del Valle, W. Grimminger, K. Götze, C. Waterhouse, H. Pralle, E. Koller, H. Salwender, F. Griesinger, K. Döhner, H. Döhner (Ulm, Germany)
| 08:45-09:00 |
588 |
|
|
RANDOMISED COMPARISON OF FLA VERSUS ADE, WITH OR WITHOUT G-CSF AND WITH OR WITHOUT ATRA, FOR HIGH-RISK AML: RESULTS OF THE MRC AML-HR TRIAL.
D.W Milligan, K. Wheatley, J.I.O. Craig, T.J. Littlewood, A.K. Burnett (Birmingham, United Kingdom)
| 09:00-09:15 |
589 |
|
|
A COMPARISON OF LOW DOSE ARA-C AND HYDROXYUREA WITH AND WITHOUT ALL RETINOIC ACID IN ACUTE MYELOID LEUKAEMIA PATIENTS NOT CONSIDERED FIT FOR CHEMOTHERAPY: RESULTS FROM NCRI LRF AML14 TRIAL
A.K. Burnett, D. Milligan, A.G. Prentice, A.H. Goldstone, M.F. McMullin, K. Wheatley (Cardiff, United Kingdom)
| 09:15-09:30 |
590 |
|
|
VACCINATION WITH WT1 INDUCES HIGH FREQUENCY MEMORY AND EFFECTOR T CELLS IN PERIPHERAL BLOOD AND BONE MARROW ASSOCIATED WITH COMPLETE REMISSION OF RECURRENT AML
A. Letsch, C. Scheibenbogen, E. Thiel, A.M. Asemissen, U. Keilholz (Berlin, Germany)
| 09:30-09:45 |
591 |
|
|
ROLE OF AUTOTRANSPLANTATION AS LATE CONSOLIDATION THERAPY IN ADULTS WITH STANDARD RISK ACUTE MYELOID LEUKEMIA AGED
A. Ganser, J. Krauter, D. Hoelzer, O.G. Ottmann, H. Martin, M. Lübbert, J. Finke, W. Heit, W. Fiedler, D. Hossfeld, L. Kanz, G. Schlimok, H. Kirchner, A. Raghavachar, W. Brugger, G. Heil (Hannover, Germany)
|